<SEC-DOCUMENT>0001140361-24-029313.txt : 20240607
<SEC-HEADER>0001140361-24-029313.hdr.sgml : 20240607
<ACCEPTANCE-DATETIME>20240607170851
ACCESSION NUMBER:		0001140361-24-029313
CONFORMED SUBMISSION TYPE:	S-8 POS
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240607
DATE AS OF CHANGE:		20240607
EFFECTIVENESS DATE:		20240607

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NU SKIN ENTERPRISES, INC.
		CENTRAL INDEX KEY:			0001021561
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				870565309
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8 POS
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-280044
		FILM NUMBER:		241030595

	BUSINESS ADDRESS:	
		STREET 1:		75 WEST CENTER ST
		STREET 2:		ATTN: GREGORY BELLISTON
		CITY:			PROVO
		STATE:			UT
		ZIP:			84601
		BUSINESS PHONE:		801-345-1000

	MAIL ADDRESS:	
		STREET 1:		75 WEST CENTER ST
		STREET 2:		ATTN: GREGORY BELLISTON
		CITY:			PROVO
		STATE:			UT
		ZIP:			84601

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NU SKIN ENTERPRISES INC
		DATE OF NAME CHANGE:	19980909

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NU SKIN ASIA PACIFIC INC
		DATE OF NAME CHANGE:	19960919
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8 POS
<SEQUENCE>1
<FILENAME>ef20030640_s8pos.htm
<DESCRIPTION>FORM S-8 POS
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solution Inc.
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right;">Registration No. 333-167690</div>
    <div style="text-align: right;">Registration No. 333-190508</div>
    <div style="text-align: right;">Registration No. 333-211617</div>
    <div style="text-align: right;">Registration No. 333-238908</div>
    <div style="text-align: right;">&#160;Registration No. 333-280044</div>
    <div>
      <div style="text-align: center;">As filed with the Securities and Exchange Commission on June 7, 2024</div>
      <div>
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
        <div>
          <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
          <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
          <div style="text-align: center; font-size: 12pt;">Washington, D.C.&#160; 20549</div>
          <div style="text-align: center; font-weight: bold;"><br>
          </div>
          <div style="text-align: center; font-weight: bold;">
            <hr noshade="noshade" align="center" style="height: 2px; width: 20%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
          <div>&#160;</div>
          <div style="text-align: center; font-weight: bold;">POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S&#8209;8 REGISTRATION STATEMENT NO. 333-167690</div>
          <div style="text-align: center; font-weight: bold;">POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S&#8209;8 REGISTRATION STATEMENT NO. 333-190508</div>
          <div style="text-align: center; font-weight: bold;">POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S&#8209;8 REGISTRATION STATEMENT NO. 333-211617</div>
          <div style="text-align: center; font-weight: bold;">POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S&#8209;8 REGISTRATION STATEMENT NO. 333-238908</div>
          <div style="text-align: center; font-weight: bold;">POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S&#8209;8 REGISTRATION STATEMENT NO. 333-280044</div>
          <div><br>
          </div>
          <div style="text-align: center; font-weight: bold;">UNDER</div>
          <div style="text-align: center; font-weight: bold;">THE SECURITIES ACT OF 1933</div>
          <div><br>
          </div>
          <div>
            <hr noshade="noshade" align="center" style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
          <br>
          <div style="text-align: center; font-size: 24pt; font-weight: bold;">NU SKIN ENTERPRISES, INC.</div>
          <div>&#160;</div>
          <div style="text-align: center;">(Exact name of registrant as specified in its charter)</div>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" border="0" id="z1985b72296b147ffb3b5cde097e0d080" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-weight: bold;">Delaware</div>
                  <div style="text-align: center;">(State or other jurisdiction</div>
                  <div style="text-align: center;">of incorporation or organization)</div>
                </td>
                <td style="width: 2%; vertical-align: top;">&#160;</td>
                <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-weight: bold;">87-0565309</div>
                  <div style="text-align: center;">(I.R.S. Employer</div>
                  <div style="text-align: center;">Identification No.)</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <div style="text-align: center; font-weight: bold;">75 West Center Street</div>
          <div style="text-align: center; font-weight: bold;">Provo, Utah 84601</div>
          <div>&#160;</div>
          <div style="text-align: center;">(Address, including zip code,</div>
          <div style="text-align: center;">of registrant&#8217;s principal executive offices)</div>
          <div>&#160;</div>
          <div style="text-align: center;">
            <hr noshade="noshade" align="center" style="height: 2px; width: 20%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
          <div style="text-align: center;"><br>
          </div>
          <div style="text-align: center; font-weight: bold;">Nu Skin Enterprises, Inc. 2010 Omnibus Incentive Plan</div>
          <div style="text-align: center; font-weight: bold;">Amended and Restated Nu Skin Enterprises, Inc. 2010 Omnibus Incentive Plan</div>
          <div style="text-align: center; font-weight: bold;">Second Amended and Restated Nu Skin Enterprises, Inc. 2010 Omnibus Incentive Plan</div>
          <div style="text-align: center; font-weight: bold;">Third Amended and Restated Nu Skin Enterprises, Inc. 2010 Omnibus Incentive Plan</div>
          <div style="text-align: center; font-weight: bold;">Nu Skin Enterprises, Inc. 2024 Omnibus Incentive Plan</div>
          <div style="text-align: center;">(Full title of the plans)</div>
          <div>&#160;</div>
          <div style="text-align: center;">
            <hr noshade="noshade" align="center" style="height: 2px; width: 20%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
          <div>&#160;</div>
          <div style="text-align: center; font-weight: bold;">Ryan S. Napierski</div>
          <div style="text-align: center; font-weight: bold;">President and Chief Executive Officer</div>
          <div style="text-align: center; font-weight: bold;">Nu Skin Enterprises, Inc.</div>
          <div style="text-align: center; font-weight: bold;">75 West Center Street</div>
          <div style="text-align: center; font-weight: bold;">Provo, Utah 84601</div>
          <div style="text-align: center; font-weight: bold;">(801) 345-1000</div>
          <div>&#160;</div>
          <div style="text-align: center;">(Name, address and telephone number,</div>
          <div style="text-align: center;">&#160;including area code, of agent for service)</div>
          <div style="text-align: center;"><br>
          </div>
          <div style="text-align: center;">
            <hr noshade="noshade" align="center" style="height: 2px; width: 20%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
          <div>&#160;</div>
          <div style="text-align: center;">Copies to:</div>
          <table cellspacing="0" cellpadding="0" border="0" id="z215531f699ba4f7c95ea85103551b001" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-weight: bold;">Roger Bivans</div>
                  <div style="text-align: center; color: #000000; font-weight: bold;">Baker &amp; McKenzie LLP</div>
                  <div style="text-align: center; color: #000000; font-weight: bold;">1900 North Pearl</div>
                  <div style="text-align: center; color: #000000; font-weight: bold;">Suite 1500</div>
                  <div style="text-align: center; color: #000000; font-weight: bold;">Dallas, TX 75201</div>
                  <div style="text-align: center; color: #000000; font-weight: bold;">(214) 978-3095</div>
                </td>
                <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
                <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-weight: bold;">Chayce D. Clark</div>
                  <div style="text-align: center; font-weight: bold;">Executive Vice President and General Counsel</div>
                  <div style="text-align: center; font-weight: bold;">Nu Skin Enterprises, Inc.</div>
                  <div style="text-align: center; font-weight: bold;">75 West Center Street</div>
                  <div style="text-align: center; font-weight: bold;">Provo, Utah 84601</div>
                  <div style="text-align: center; font-weight: bold;">(801) 345-1000</div>
                </td>
              </tr>

          </table>
          <div style="text-align: center;"><br>
          </div>
          <div style="text-align: center;">
            <hr noshade="noshade" align="center" style="height: 2px; width: 20%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
          <div>&#160;</div>
          <div>Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221;
            &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" id="zc2e6eea85320414884b2bbd6d89097eb" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 59.53%; vertical-align: top;">
                  <div>Large accelerated filer&#160; &#9745;</div>
                </td>
                <td style="width: 40.47%; vertical-align: top;">
                  <div>Accelerated filer&#160; &#9744;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 59.53%; vertical-align: top;">
                  <div>Non-accelerated filer&#160; &#9744;</div>
                </td>
                <td style="width: 40.47%; vertical-align: top;">
                  <div>Smaller reporting company&#160; &#9744;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 59.53%; vertical-align: top;">&#160;</td>
                <td style="width: 40.47%; vertical-align: top;">
                  <div>Emerging growth company&#160; &#9744;</div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the
            Securities Act.&#160; &#9744;</div>
          <div> <br>
          </div>
          <div style="text-align: center;">
            <hr noshade="noshade" align="center" style="height: 2px; width: 20%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
          <div>&#160;</div>
          <div>
            <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <!--PROfilePageNumberReset%Num%1%%%-->
          <div style="text-align: center; font-weight: bold;">EXPLANATORY NOTE</div>
          <div>&#160;</div>
          <div>Nu Skin Enterprises, Inc. (the &#8220;Registrant&#8221;), previously filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) the following registration statements on Form S-8 (collectively, the &#8220;Prior Registration Statements&#8221;) on the dates set
            forth below to register shares of the Registrant&#8217;s Class A Common Stock, $0.001 par value per share (the &#8220;Common Stock&#8221;):</div>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" id="ze1e85f4f776d4451ba6fcbd0530ab438" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>Registration No. 333-167690 on June 23, 2010 to register 7,000,000 shares of Common Stock under the Registrant&#8217;s 2010 Omnibus Incentive Plan and its amendments (collectively, the &#8220;Prior Plan&#8221;)</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z056eb2c2bf994d2c95f955b914d4971e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>Registration No. 333-190508 on August 9, 2013 to register 3,247,616 shares of Common Stock under the Prior Plan</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z7941982e13f840019f7c3e4e13f36ce8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>Registration No. 333-211617 on May 25, 2016 to register 3,752,694 shares of Common Stock under the Prior Plan</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="zaea51c7748af4cb68530b5ec4fd5c89f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>Registration No. 333-238908 on June 3, 2020 to register 5,896,993 shares of Common Stock under the Prior Plan</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" id="z0989df820e3b41119d2e1827a215ad01" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>Registration No. 333-280044 on June 7, 2024 to register 1,219,919 shares of Common Stock under the Registrant&#8217;s Nu Skin Enterprises, Inc. 2024 Omnibus Incentive Plan (the &#8220;2024 Plan&#8221;)</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <div>The Registrant&#8217;s stockholders approved the 2024 Plan at the Registrant&#8217;s 2024 Annual Meeting of Stockholders on June 5, 2024 (the &#8220;Effective Date&#8221;), and accordingly, no further awards may be granted under the Prior Plan. Pursuant to the
            terms of the 2024 Plan, the number of shares of Common Stock reserved and available for grant and issuance pursuant to the 2024 Plan is equal to the sum of (i) 1,219,919 shares of Common Stock (the &#8220;Newly Authorized Shares&#8221;), plus (ii) the
            number of shares of Common Stock which as of the Effective Date are available for issuance under the Prior Plan (the &#8220;Rollover Shares&#8221;), plus (iii) the number of shares of Common Stock subject to outstanding awards granted under the Prior Plan
            that are therefore issuable under the 2024 Plan (the &#8220;Recycled Shares&#8221; and together with the &#8220;Rollover Shares,&#8221; the &#8220;Transferred Shares&#8221;).</div>
          <div>&#160;</div>
          <div>The Registrant is filing this Post-Effective Amendment No. 1 to the Prior Registration Statements (the &#8220;Post-Effective Amendment&#8221;) pursuant to Regulation S-K Item 512(a)(1)(iii) and SEC Compliance and Disclosure Interpretation 126.43 to
            amend each of the Prior Registration Statements to register the offer of the Transferred Shares under the 2024 Plan.</div>
          <div>&#160;</div>
          <div>In accordance with SEC Compliance and Disclosure Interpretation 126.43, no new filing fee is due upon the filing of this Post&#8209;Effective Amendment. For the avoidance of doubt, the Registrant is not hereby registering any additional shares of
            Common Stock on this Post-Effective Amendment that were not previously registered on the Prior Registration Statement or that were not previously approved by the Registrant&#8217;s stockholders as of the Effective Date. Contemporaneously with the
            filing of this Post&#8209;Effective Amendment, the Company is filing a Registration Statement on Form S-8 to register the Newly Authorized Shares under the Plan.</div>
          <div>&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">1</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div style="text-align: center; font-weight: bold;">PART I</div>
          <div>&#160;</div>
          <div style="text-align: center; font-weight: bold;">INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</div>
          <div>&#160;</div>
          <div>The documents containing the information specified in Item 1 and Item 2 of Part I of Form S-8 will be sent or given to participants as specified by Rule 428(b)(1) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). In
            accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;Commission&#8221;) and the instructions to Form S-8, such documents are not being filed with the Commission either as part of this Post-Effective Amendment
            or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act.</div>
          <div>&#160;</div>
          <div style="text-align: center; font-weight: bold;">PART II</div>
          <div>&#160;</div>
          <div style="text-align: center; font-weight: bold;">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</div>
          <div>&#160;</div>
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z3f8dab635ed647cdbcb2bd9f11d49c9f" class="DSPFListTable">

                <tr style="vertical-align: top;">
                  <td style="text-align: right; vertical-align: top; width: 72pt;">
                    <div style="text-align: left;"><font style="font-weight: bold;">Item 3.</font></div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div><font style="font-weight: bold;">Incorporation of Documents by Reference.</font></div>
                  </td>
                </tr>

            </table>
          </div>
          <div>&#160;</div>
          <div style="text-indent: 22.5pt;">The following documents, which have been filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) by Nu Skin Enterprises, Inc. (the &#8220;Company&#8221;), are incorporated by reference in this Post-Effective
            Amendment, except to the extent that information therein is deemed furnished and not filed pursuant to securities laws and regulations:</div>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" id="zc89709a49f7c4b099fcc5e85fb85ef35" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 54pt;">&#160;</td>
                <td style="width: 18pt; vertical-align: top;">(a)</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the Company&#8217;s Annual Report on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1021561/000114036124008111/ef20015265_10k.htm">Form 10&#8209;K</a> for the fiscal year ended December 31, 2023;</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" id="z69d9f68ea2554ac49fe00d62d893053e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">(b)</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the Company&#8217;s Quarterly Report on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1021561/000114036124025012/ef20026282_10q.htm">Form 10&#8209;Q</a> for the quarter ended March 31, 2024;</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" id="zec25ca0a0caa4bdcb9b849096d04c939" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">(c)</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the Company&#8217;s Current Reports on Form 8-K filed on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1021561/000114036124005870/ef20020750_8k.htm">February 6, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1021561/000114036124007981/ef20021676_8k.htm">February 14, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1021561/000114036124013913/ef20024334_8k.htm">March
                      18, 2024</a>&#160;and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001021561/000114036124029122/ef20030699_8k.htm">June 6, 2024</a>; and</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" id="z2282c6f744244793aca741c46bb52ef8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">(d)</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the description of the Company&#8217;s Class A Common Stock, par value $0.001 per share, filed as <a href="https://www.sec.gov/Archives/edgar/data/1021561/000114036124008111/ef20015265_ex4-2.htm">Exhibit 4.2</a> to the Company&#8217;s Annual
                    Report on Form 10-K for the fiscal year ended December 31, 2023, filed on February 15, 2024, together with any amendment or report filed with the Commission for the purpose of updating such description.</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <div>All documents filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), subsequent to the date hereof and prior to the filing of a post-effective amendment
            which indicates that all securities offered hereby have been sold or which deregisters all securities remaining unsold shall be deemed to be incorporated by reference herein and to be a part hereof from the respective dates of filing of such
            documents.</div>
          <div>&#160;</div>
          <div>Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Post-Effective Amendment to the extent that a statement contained herein or
            in any other subsequently filed document that also is, or is deemed to be, incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded,
            to constitute a part of this Post-Effective Amendment.</div>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" id="z51eb9dc9e2394fd5a53bcc8520a4be65" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 72pt; vertical-align: top; font-weight: bold;">Item 4.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-weight: bold;">Description of Securities.</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <div>Not applicable.</div>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" id="z65debc05778a48bfb481d04d209b17d2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 72pt; vertical-align: top; font-weight: bold;">Item 5.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-weight: bold;">Interests of Named Experts and Counsel.</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <div>Not applicable.</div>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" id="zf3b4b915cee34e3595fb414f2ca519e9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 72pt; vertical-align: top; font-weight: bold;">Item 6.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-weight: bold;">Indemnification of Directors and Officers.</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <div style="font-style: italic; font-weight: bold;">Indemnification</div>
          <div>&#160;</div>
          <div>The registrant is incorporated under the laws of the State of Delaware. Section 145 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;) provides that a Delaware corporation may indemnify persons who were, are or are threatened to be made
            parties to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of such corporation), by reason of the fact that such person is or was
            a director, officer, employee or agent of such corporation, or is or was serving at the request of such corporation as a director, officer, employee or agent of another corporation or enterprise. The indemnity may include expenses (including
            attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding, provided such person acted in good faith and in a manner the person reasonably
            believed to be in or not opposed to the corporation&#8217;s best interests and, with respect to any criminal action or proceeding, had no reasonable cause to believe that his or her conduct was unlawful. The registrant&#8217;s certificate of incorporation
            and bylaws provide for the indemnification of the registrant&#8217;s officers and directors to the fullest extent permitted by the DGCL. The registrant believes that such indemnification is necessary to attract and retain qualified persons as
            directors and officers. The registrant has also entered into separate indemnification agreements with each of its directors and executive officers.</div>
          <div>&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div style="font-style: italic; font-weight: bold;">Liability Insurance</div>
          <div>&#160;</div>
          <div>Section 145 of the DGCL also permits a Delaware corporation to purchase and maintain insurance on behalf of its directors and officers. The registrant&#8217;s certificate of incorporation and bylaws permit the registrant to purchase such insurance
            on behalf of its directors and officers. The registrant believes that such insurance is necessary to attract and retain qualified persons as directors and officers. The registrant has purchased such insurance on behalf of its directors and
            officers.</div>
          <div>&#160;</div>
          <div style="font-style: italic; font-weight: bold;">Limitation of Liability</div>
          <div>&#160;</div>
          <div>Section 102(b)(7) of the DGCL provides that the certificate of incorporation of a corporation may contain a provision eliminating or limiting the personal liability of a director or officer to the corporation or its stockholders for monetary
            damages for breach of fiduciary duty as a director or officer, provided that such provision shall not eliminate or limit the liability of: (i) a director or officer for any breach of the director&#8217;s or officer&#8217;s duty of loyalty to the
            corporation or its stockholders; (ii) a director or officer for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; (iii) a director under Section 174 of the DGCL; (iv) a director or
            officer for any transaction from which the director or officer derived an improper personal benefit; and (v) an officer in any action by or in the right of the corporation. The registrant&#8217;s certificate of incorporation provides for, to the
            fullest extent permitted by the DGCL, elimination or limitation of liability of its directors to the registrant or its stockholders for breach of fiduciary duty as a director.</div>
          <div>&#160;</div>
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z908e72998bb14779b4a87e419215ac3b" class="DSPFListTable">

                <tr style="vertical-align: top;">
                  <td style="text-align: right; vertical-align: top; width: 72pt;">
                    <div style="text-align: left;"><font style="font-weight: bold;">Item 7.</font></div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div><font style="font-weight: bold;">Exemption from Registration Claimed.</font></div>
                  </td>
                </tr>

            </table>
          </div>
          <div>&#160;</div>
          <div>Not applicable.</div>
          <div>&#160;</div>
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="ze518099a951947938daa6850864bde95" class="DSPFListTable">

                <tr style="vertical-align: top;">
                  <td style="text-align: right; vertical-align: top; width: 72pt;">
                    <div style="text-align: left;"><font style="font-weight: bold;">Item 8.</font></div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div><font style="font-weight: bold;">Exhibits.</font></div>
                  </td>
                </tr>

            </table>
          </div>
          <div>&#160;</div>
          <div>Unless otherwise noted, the SEC file number for exhibits incorporated by reference is 001-12421.</div>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" border="0" id="zb3f1183d4e844efaa776c238aec5fc60" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 11.28%; vertical-align: bottom;">
                  <div style="text-align: center; font-weight: bold;">Exhibit</div>
                  <div style="text-align: center; font-weight: bold;"><u>Number</u></div>
                </td>
                <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
                <td style="width: 88.72%; vertical-align: bottom;">
                  <div style="font-weight: bold;"><u>Description</u></div>
                </td>
              </tr>
              <tr>
                <td style="width: 11.28%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center;">4.1</div>
                </td>
                <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
                <td style="width: 88.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                  <div><a href="https://www.sec.gov/Archives/edgar/data/1021561/0000950109-96-005995.txt">Amended and Restated Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Registration Statement on
                      Form S-1 filed September 16, 1996, File No. 333-12073).</a></div>
                </td>
              </tr>
              <tr>
                <td style="width: 11.28%; vertical-align: top;">
                  <div style="text-align: center;">4.2</div>
                </td>
                <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
                <td style="width: 88.72%; vertical-align: bottom;">
                  <div><a href="https://www.sec.gov/Archives/edgar/data/1021561/000102156110000024/ex3-2.htm">Certificate of Amendment to the Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.2 to the Company&#8217;s
                      Annual Report on Form 10-K for the year ended December 31, 2009, filed March 1, 2010).</a></div>
                </td>
              </tr>
              <tr>
                <td style="width: 11.28%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center;">4.3</div>
                </td>
                <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
                <td style="width: 88.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                  <div><a href="https://www.sec.gov/Archives/edgar/data/1021561/000103393205000011/ex3-3.htm">Certificate of Designation, Preferences and Relative Participating, Optional and Other Special Rights of Preferred Stock and Qualifications,
                      Limitations and Restrictions Thereof (incorporated by reference to Exhibit 3.3 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004, filed March 15, 2005).</a></div>
                </td>
              </tr>
              <tr>
                <td style="width: 11.28%; vertical-align: top;">
                  <div style="text-align: center;">4.4</div>
                </td>
                <td style="width: 1%; vertical-align: bottom;" colspan="1">&#160;</td>
                <td style="width: 88.72%; vertical-align: bottom;">
                  <div><a href="https://www.sec.gov/Archives/edgar/data/1021561/000114036124005870/ef20020750_ex3-1.htm">Fifth Amended and Restated Bylaws of Nu Skin Enterprises, Inc. (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current
                      Report on Form 8-K filed February 6, 2024).</a></div>
                </td>
              </tr>
              <tr>
                <td style="width: 11.28%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center;">4.5</div>
                </td>
                <td style="width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
                <td style="width: 88.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                  <div><a href="https://www.sec.gov/Archives/edgar/data/1021561/000114036123007348/brhc10046901_ex4-1.htm">Specimen Form of Stock Certificate for Class A Common Stock (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Annual Report
                      on Form 10-K for the year ended December 31, 2022, filed February 16, 2023).</a></div>
                </td>
              </tr>
              <tr>
                <td style="width: 11.28%; vertical-align: top;">
                  <div style="text-align: center;">23.1*</div>
                </td>
                <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
                <td style="width: 88.72%; vertical-align: top;">
                  <div><a href="ef20030640_ex23-1.htm">Consent of PricewaterhouseCoopers LLP, independent registered public accounting firm.</a></div>
                </td>
              </tr>
              <tr>
                <td style="width: 11.28%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center;">24.1*</div>
                </td>
                <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
                <td style="width: 88.72%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div><a href="#POWEROFATTORNEY">Power of Attorney (included on the signature page of this Post-Effective Amendment).</a></div>
                </td>
              </tr>
              <tr>
                <td style="width: 11.28%; vertical-align: top;">
                  <div style="text-align: center;">99.1</div>
                </td>
                <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
                <td style="width: 88.72%; vertical-align: top;">
                  <div><a href="https://www.sec.gov/Archives/edgar/data/1021561/000102156110000053/stockincentplan.htm">Nu Skin Enterprises, Inc. 2010 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form
                      8-K filed on June 2, 2010).</a></div>
                </td>
              </tr>
              <tr>
                <td style="width: 11.28%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center;">99.2</div>
                </td>
                <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
                <td style="width: 88.72%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div><a href="https://www.sec.gov/Archives/edgar/data/1021561/000102156113000065/incentive2010plan.htm">Amended and Restated Nu Skin Enterprises, Inc. 2010 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company&#8217;s
                      Current Report on Form 8-K filed on June 7, 2013).</a></div>
                </td>
              </tr>
              <tr>
                <td style="width: 11.28%; vertical-align: top;">
                  <div style="text-align: center;">99.3</div>
                </td>
                <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
                <td style="width: 88.72%; vertical-align: top;">
                  <div><a href="https://www.sec.gov/Archives/edgar/data/1021561/000102156116000134/ex10-1.htm">Second Amended and Restated Nu Skin Enterprises, Inc. 2010 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company&#8217;s
                      Current Report on Form 8-K filed May 24, 2016).</a></div>
                </td>
              </tr>
              <tr>
                <td style="width: 11.28%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center;">99.4</div>
                </td>
                <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
                <td style="width: 88.72%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div><a href="https://www.sec.gov/Archives/edgar/data/1021561/000114036120012979/ex99_1.htm">Third Amended and Restated 2010 Omnibus Incentive Plan (incorporated by reference to Exhibit 99.1 to the Company&#8217;s Registration Statement on Form
                      S-8 filed June 3, 2020, file no. 333-238908).</a></div>
                </td>
              </tr>
              <tr>
                <td style="width: 11.28%; vertical-align: top;">
                  <div style="text-align: center;">99.5</div>
                </td>
                <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
                <td style="width: 88.72%; vertical-align: top;">
                  <div><a href="https://www.sec.gov/Archives/edgar/data/1021561/000114036124029122/ef20030699_ex10-1.htm">Nu Skin Enterprises, Inc. 2024 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on
                      Form 8-K filed June 6, 2024).<br>
                    </a></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div>
            <div>* Filed herewith.</div>
            <div> <br>
            </div>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z35f462a9511848debbe1addbaf226ff9" class="DSPFListTable">

                <tr style="vertical-align: top;">
                  <td style="text-align: right; vertical-align: top; width: 72pt;">
                    <div style="text-align: left;"><font style="font-weight: bold;">Item 9.</font></div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div><font style="font-weight: bold;">Undertakings.</font></div>
                  </td>
                </tr>

            </table>
          </div>
          <div>&#160;</div>
          <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned registrant hereby undertakes:</div>
          <div>&#160;</div>
          <div style="text-indent: 36pt; margin-left: 36pt;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</div>
          <div>&#160;</div>
          <div style="text-indent: 36pt; margin-left: 72pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</div>
          <div>&#160;</div>
          <div style="text-indent: 36pt; margin-left: 72pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which,
            individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement.&#160; Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of
            securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if,
            in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and</div>
          <div>&#160;</div>
          <div style="text-indent: 36pt; margin-left: 72pt;">(iii)&#160;&#160; &#160; &#160;&#160;&#160; To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the
            registration statement;</div>
          <div>&#160;</div>
          <div style="margin-left: 36pt;"><font style="font-style: italic;">Provided</font>, <font style="font-style: italic;">however</font>, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the registration statement is on Form S-8, and the
            information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are
            incorporated by reference in the registration statement.</div>
          <div>&#160;</div>
          <div style="text-indent: 36pt; margin-left: 36pt;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the
            securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
          <div>&#160;</div>
          <div style="text-indent: 36pt; margin-left: 36pt;">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</div>
          <div>&#160;</div>
          <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant&#8217;s annual report pursuant to Section 13(a) or Section
            15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new
            registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
          <div>&#160;</div>
          <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or
            otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.&#160; In the event that a claim for indemnification
            against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such
            director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate
            jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</div>
          <div>&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div style="text-align: center; font-weight: bold;">SIGNATURES</div>
          <div>&#160;</div>
          <div>Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S&#8209;8 and has duly caused this registration statement to be
            signed on its behalf by the undersigned, thereunto duly authorized, in the City of Provo, State of Utah, on this 7th day of June, 2024.</div>
          <div>&#160;
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zbff7096335f5493898a7eb708c6eace9">

                <tr>
                  <td style="width: 50%;"><br>
                  </td>
                  <td rowspan="1" colspan="2"><font style="font-weight: bold;">NU SKIN ENTERPRISES, INC.</font><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 50%;"><br>
                  </td>
                  <td style="width: 3%;"><br>
                  </td>
                  <td style="width: 47%;"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 50%; padding-bottom: 2px;"><br>
                  </td>
                  <td style="width: 3%; padding-bottom: 2px;">By</td>
                  <td style="width: 47%; border-bottom: 2px solid rgb(0, 0, 0);"><font style="color: #000000;"> /s/ Ryan S. Napierski</font> <u><br>
                    </u></td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;"><br>
                  </td>
                  <td style="width: 4%;"><br>
                  </td>
                  <td style="width: 46%;">Name:&#160; Ryan S. Napierski</td>
                </tr>
                <tr>
                  <td style="width: 50%;"><br>
                  </td>
                  <td style="width: 4%;"><br>
                  </td>
                  <td style="width: 46%;">Title:&#160; President and Chief Executive Officer</td>
                </tr>

            </table>
          </div>
          <div>&#160;</div>
          <div style="text-align: center; font-weight: bold;"><a name="POWEROFATTORNEY"><!--Anchor--></a>POWER OF ATTORNEY</div>
          <div>&#160;</div>
          <div>KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Ryan S. Napierski and Chayce D. Clark, and each of them, his or her true and lawful attorneys-in-fact and agents, with full power
            of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to the registration statement (including post-effective amendments), and to file the same,
            with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting each of said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing
            requisite and necessary to be done in and about the premises, as full to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their
            substitute, may lawfully do or cause to be done by virtue hereof.</div>
          <div>&#160;</div>
          <div>Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities indicated and on the dates indicated.</div>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" border="0" id="z417791ca7ac74f0baf27f7d4d59ece2f" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 30%; vertical-align: top;">
                  <div style="text-align: center; margin-right: 13.6pt; color: #000000; font-weight: bold;"><u>Signature</u></div>
                </td>
                <td style="width: 40%; vertical-align: top;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><u>Title</u></div>
                </td>
                <td style="width: 30%; vertical-align: top;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><u>Date</u></div>
                </td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="margin-right: 4.6pt; color: #000000;">/s/ Steven J. Lund<br>
                  </div>
                </td>
                <td style="width: 40%; vertical-align: top; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0);">Executive Chairman of the Board</div>
                </td>
                <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
                  <div style="text-align: center;">June 7, 2024</div>
                </td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;Steven J. Lund</td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="margin-right: 4.3pt; color: #000000;">/s/ Ryan S. Napierski<br>
                  </div>
                </td>
                <td style="width: 40%; vertical-align: top; padding-bottom: 2px;">
                  <div style="color: #000000;">President, Chief Executive Officer and Director</div>
                </td>
                <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
                  <div style="text-align: center;">June 7, 2024</div>
                </td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">
                  <div style="margin-right: 4.3pt; color: #000000;">Ryan S. Napierski</div>
                </td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">
                  <div style="color: #000000;">(Principal Executive Officer)</div>
                </td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="margin-right: 4.3pt; color: #000000;">/s/ James D. Thomas<br>
                  </div>
                </td>
                <td style="width: 40%; vertical-align: top; padding-bottom: 2px;">
                  <div style="color: #000000;">Chief Financial Officer</div>
                </td>
                <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
                  <div style="text-align: center;">June 7, 2024</div>
                </td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;James D. Thomas</td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">
                  <div style="color: #000000;">(Principal Financial Officer and Accounting Officer)</div>
                </td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="margin-right: 4.3pt; color: #000000;">/s/ Emma S. Battle<br>
                  </div>
                </td>
                <td style="width: 40%; vertical-align: top; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0);">Director</div>
                </td>
                <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
                  <div style="text-align: center;">June 7, 2024</div>
                </td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">
                  <div style="margin-right: 4.3pt; color: #000000;">Emma S. Battle</div>
                </td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="margin-right: 4.3pt; color: #000000;">/s/ Daniel W. Campbell<br>
                  </div>
                </td>
                <td style="width: 40%; vertical-align: top; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0);">Director</div>
                </td>
                <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
                  <div style="text-align: center;">June 7, 2024</div>
                </td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;Daniel W. Campbell</td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="margin-right: 4.3pt; color: #000000;">/s/ Laura Nathanson<br>
                  </div>
                </td>
                <td style="width: 40%; vertical-align: top; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0);">Director</div>
                </td>
                <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
                  <div style="text-align: center;">June 7, 2024</div>
                </td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;Laura Nathanson</td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="margin-right: 4.3pt; color: #000000;">/s/ Thomas R. Pisano<br>
                  </div>
                </td>
                <td style="width: 40%; vertical-align: top; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0);">Director</div>
                </td>
                <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
                  <div style="text-align: center;">June 7, 2024</div>
                </td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;Thomas R. Pisano</td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="margin-right: 4.3pt; color: #000000;">/s/ Zheqing Shen<br>
                  </div>
                </td>
                <td style="width: 40%; vertical-align: top; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0);">Director</div>
                </td>
                <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
                  <div style="text-align: center;">June 7, 2024</div>
                </td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;Zheqing Shen</td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="margin-right: 4.3pt; color: #000000;">/s/ Edwina D. Woodbury<br>
                  </div>
                </td>
                <td style="width: 40%; vertical-align: top; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0);">Director</div>
                </td>
                <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
                  <div style="text-align: center;">June 7, 2024</div>
                </td>
              </tr>
              <tr>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;Edwina D. Woodbury</td>
                <td style="width: 40%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 30%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>

          </table>
          <div><br>
          </div>
          <div><br>
          </div>
          <div style="text-align: center;"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
          <div>
            <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
        </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ef20030640_ex23-1.htm
<DESCRIPTION>CONSENT OF INDEPENDENT PUBLIC ACCOUNTING FIRM
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solution Inc.
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 23.1</font><br>
    </div>
    <div style="text-align: right;"> <br>
    </div>
    <div>
      <div style="text-align: center; color: #000000;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
      <div><br>
      </div>
      <div style="color: #000000;">We hereby consent to the incorporation by reference in this Post-Effective Amendment No. 1 to the Registration Statements on Form S-8 (No. 333-167690, No. 333-190508, No. 333-211617, No. 333-238908, and No. 333-280044) of
        Nu Skin Enterprises, Inc. of our report dated February 14, 2024 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in Nu Skin Enterprises, Inc.&#8217;s Annual Report on Form 10-K for the
        year ended December&#8239;31, 2023.</div>
      <div><br>
      </div>
      <div style="color: #000000;">/s/ PricewaterhouseCoopers LLP</div>
      <div style="color: #000000;">Salt Lake City, Utah</div>
      <div style="color: #000000;">June 7, 2024</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div>&#160;</div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
